Instil Bio Inc.
TIL | NASDAQ
$6.57
-$0.23 (-3.38%)
Nov 2, 2026, 2:24 PM ET · Market open
Market Data
Market Cap $44.56M
Enterprise Value $-19.89M
Beta 1.94
Average Volume 22.17K
Shares Outstanding (Diluted) 6.78M
Shares Change YoY 2.8%
Institutional Ownership 28.07%
Exchange NASDAQ
ISIN US45783C2008
Price Performance
Price Change 1M -9.0%
Price Change 3M -9.0%
Price Change 6M -16.2%
Price Change YTD -40.3%
Price Change 1Y -59.7%
Price Change 3Y -12.4%
Price Change 5Y -98.5%
1M CAGR (ann.) -4.1%
1Y CAGR (ann.) -61.6%
5Y CAGR (ann.) -54.9%
All-Time CAGR -53.9%
Valuation
PE Ratio -1.52
Forward PE N/A
PEG Ratio -0.01
Forward PEG 0.02
PS Ratio N/A
Forward PS 5.60
PB Ratio 0.43
P/FCF Ratio -1.95
P/Adj. FCF Ratio -1.59
P/OCF Ratio -1.95
EV/Sales N/A
EV/EBIT 0.67
EV/EBITDA 0.67
EV/FCF 0.84
Earnings Yield -65.7%
FCF Yield -51.2%
Adj. FCF Yield -62.9%
Financial Health
Net Cash $67.84M
Total Debt $3.67M
Cash & Short-Term Investments $69.68M
Total Assets $197.71M
Current Ratio 21.67
Quick Ratio 21.67
Debt / Equity Ratio 0.03
Debt / EBITDA -0.12
Debt / FCF -0.16
OCF / Debt -6.43
Interest Coverage -6.59
Altman Z-Score -4.98
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -22.9%
Returns
Return on Assets -15.3%
Return on Equity -26.8%
Return on Invested Capital -18.6%
Return on Capital Employed -18.6%
Return on Tangible Assets -15.3%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 58.4%
EPS CAGR 5Y 1.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y 39.3%
FCF CAGR 5Y 52.8%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 3
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 16, 2026
EPS Estimate (next Q) -$0.17
EPS Growth Est (next Q) -91.5%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $35.00
Price Target Upside 414.7%
Cash Flow
Operating Cash Flow $-23.61M
Free Cash Flow $-23.61M
Adj. Free Cash Flow $-29.01M
FCF Per Share -$3.48
OCF Per Share -$3.48
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-24K
Operating Income $-36.18M
EBITDA $-29.61M
Net Income $-30.28M
EPS (Diluted) -$4.47
Revenue / Employee N/A
Profit / Employee $-1.78M
Employees 17
Add to Watchlist
Select watchlists to add or remove TIL